BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perrotti V, Caponio VCA, Mascitti M, Lo Muzio L, Piattelli A, Rubini C, Capone E, Sala G. Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review. Cancers (Basel) 2021;13:3126. [PMID: 34206707 DOI: 10.3390/cancers13133126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rioja-Blanco E, Arroyo-Solera I, Álamo P, Casanova I, Gallardo A, Unzueta U, Serna N, Sánchez-García L, Quer M, Villaverde A, Vázquez E, León X, Alba-Castellón L, Mangues R. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res 2022;41:49. [PMID: 35120582 DOI: 10.1186/s13046-022-02267-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Erber R, Spoerl S, Mamilos A, Krupar R, Hartmann A, Ruebner M, Taxis J, Wittenberg M, Reichert TE, Spanier G, Spoerl S. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma. Int J Mol Sci 2021;23:87. [PMID: 35008509 DOI: 10.3390/ijms23010087] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Madera M, Tirado Amador L, Leal Acosta C. Therapeutic Options in Unresectable Oral Squamous Cell Carcinoma: A Systematic Review. Cancer Manag Res 2021;13:6705-19. [PMID: 34471384 DOI: 10.2147/CMAR.S283204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]